Why Core Laboratories Inc’s (CLB) Stock Is Down 4.39%

By Tudor Pop
September 26, 2024
Featured Tickers:
CLB

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Core Laboratories Inc before investing.

In this article, we go over a few key elements for understanding Core Laboratories Inc’s stock price such as:

  • Core Laboratories Inc’s current stock price and volume
  • Why Core Laboratories Inc’s stock price changed recently
  • Upgrades and downgrades for CLB from analysts
  • CLB’s stock price momentum as measured by its relative strength

About Core Laboratories Inc (CLB)

Before we jump into Core Laboratories Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. In addition, the Company assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. The Company has two segments. Reservoir Description segment provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry. In addition, it provides reservoir description capabilities. Production Enhancement segment provides integrated diagnostic services. The Company has approximately 70 offices in more than 50 countries.

Want to learn more about Core Laboratories Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Core Laboratories Inc.

Learn More About A+ Investor

Core Laboratories Inc’s Stock Price as of Market Close

As of September 26, 2024, 4:00 PM, CST, Core Laboratories Inc’s stock price was $17.85.

Core Laboratories Inc is down 4.39% from its previous closing price of $18.67.

During the last market session, Core Laboratories Inc’s stock traded between $18.57 and $19.10. Currently, there are 46.91 million shares of Core Laboratories Inc stock available for purchase.

Core Laboratories Inc’s price-earnings (P/E) ratio is currently at 37.5, which is high compared to the Business Support Services industry median of 23.3. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Core Laboratories Inc Stock Price History

Core Laboratories Inc’s (CLB) price is currently down 8.74% so far this month.

During the month of September, Core Laboratories Inc’s stock price has reached a high of $19.62 and a low of $16.39.

Over the last year, Core Laboratories Inc has hit prices as high as $25.20 and as low as $13.82. Year to date, Core Laboratories Inc’s stock is down 11.94%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Core Laboratories Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of September 25, 2024,, no analysts have changed their rating of Core Laboratories Inc’s stock over the last month.

Additionally, you'll want to evaluate Core Laboratories Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Core Laboratories Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Core Laboratories Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Core Laboratories Inc (CLB) by visiting AAII Stock Evaluator.

Relative Price Strength of Core Laboratories Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 25, 2024, Core Laboratories Inc has a weighted four-quarter relative price strength of -10.70%, which translates to a Momentum Score of 29 and is considered to be Weak.

Want to learn more about how Core Laboratories Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Core Laboratories Inc Stock Price: Bottom Line

As of September 26, 2024, Core Laboratories Inc’s stock price is $17.85, which is down 4.39% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Core Laboratories Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
O'Shaughnessy Tiny Titans
Screen:
23.7%
Annual Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.